PORTLAND, Ore. — Adults with low incomes reported lower depression following three months of psilocybin treatment in a first-of-its-kind study released Tuesday. The study conducted by the National ...

Gilead Sciences (NASDAQ:GILD) on Wednesday announced a collaboration with the Swiss non-profit The Global Fund to accelerate access to lenacapavir, its newly approved HIV PrEP therapy, for people ...

The Health Resources and Services Administration (HRSA) announced $1.4 billion in additional federal funding to combat the national HIV/AIDS epidemic, which the Biden White House has set out to end by ...

PORTLAND, Ore. — For the first time, a scientific study has examined Oregon's pioneering model for psilocybin therapy, reflecting on a program now two years underway. Psilocybin is the psychedelic ...

The county’s largest provider of drug and alcohol treatment services for low-income residents is to reopen a drug addiction recovery and detox center in Santa Rosa, restoring a key element to the ...

It is not clear what effect socioeconomic factors have on adherence to antiretroviral therapy (ART) among patients in low- and middle-income countries. We performed a systematic review of the ...

A Fayetteville-based autism therapy provider says it has been forced to pause services for some children after Amerigroup, a managed care organization that ...